Popular Articles

Tapentadol Tablets For Moderate To Scute Pain In Over 18s Now Available For Use In The United States
German pain expert company GrÃønenthal GmbH announces that the new centrally acting analgesic tapentadol is now available in the United States. The drug is indicated for the relief of moderate to severe acute pain in patients 18 years of age and older. Approval was given by the US Food and Drug Administration (FDA) in November 2008 for tapentadol (NUCYNTATM) tablets. With the cooperation of GrÃønenthal and its marketing partner Ortho-McNeil-Janssen Pharmaceuticals, Inc., the medication can now be prescribed by physicians and other appropriate health care professionals in the United States.
generic viagra online
Obama Pledges $73M To Zimbabwe
Following talks with Zimbabwean Prime Minister Morgan Tsvangirai at the White House Friday, President Obama pledged $73 million in aid to the country, AFP/Google.com reports (Carmichael, AFP/Google.com, 6/13). The U.S. aid, however "will not be going to the government directly because we continue to be concerned about consolidating democracy, human rights and rule of law," Obama said (Stolberg, New York Times, 6/13), but channeled through appropriate aid agencies (ZimOnline, 6/15).
News of the day
To Defeat Tuberculosis, Higher Drug Doses Needed
The typical dose of a medication considered pivotal in treating tuberculosis effectively is much too low to account for modern-day physiques, UT Southwestern Medical Center researchers said.
Health Insurance

MS Society-funded Study Unlocks Part Of The Mystery Of Remyelination In MS

Researchers working in Cambridge and San Francisco have discovered clues about how stem cells promote myelin repair. The study, published earlier this week in the journal Genes and Development, was partly funded by the MS Society and took place at the MS Society Cambridge Centre for Myelin Repair. Researchers looked at what factors are important for remyelination (the process by which damaged myelin is repaired by brain cells) in MS and discovered that a cell signalling pathway called the Wnt pathway is involved in remyelination. Cell signalling pathways are complex processes in cells that, when turned on or off, can change the role of that particular cell in the body. The Wnt pathway is an important pathway for all stages of development, including development in the womb, and for this reason researchers have been studying it for years. In this case, researchers have shown for the first time that the Wnt pathway is involved in remyelination - and that when it is not working properly cells cannot remyelinate properly. The study looked specifically at the Wnt pathway in oligodendrocytes (specialised brain cells that are responsible for making and repairing myelin). They found that if the Wnt pathway is over-active then remyelination is impaired, suggesting that the Wnt pathway is not functioning as it should in MS lesions. This is potentially a good therapeutic target to help promote myelin repair in people with MS. The Wnt pathway has been the subject of much study in the cancer biology field for several years as it can be over or under-active in many types of cancer. If the research is further developed, it is hoped that the existing knowledge in the cancer biology field will speed up the process of drug discovery. There are currently no drugs available that aim to repair myelin as all current treatments for MS involve altering the immune system. Knowledge of the Wnt pathway in remyelination of MS lesions may lead to treatments in years to come. MS Society Director of Research, Jayne Spink, said: "We are delighted with the outcome of this outstanding research, which gives us greater knowledge of the mechanics of MS. This works opens up new avenues of research and lends itself to more study. Being able to uncover the secrets behind the damage caused in MS will take us forward in our understanding of this debilitating condition." This study was part-funded by the MS Society as part of its initiative to invest more res into research on myelin repair and nerve regeneration. Part of the study was completed at the MS Society Cambridge Centre for Myelin Repair and used tissue from the MS Society Tissue Bank. MS Society


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):